Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma
J Wei, H Jiang, Y Zhou, J Tian, FS Furtado… - Digestive and Liver …, 2023 - Elsevier
The high postoperative recurrence rates in hepatocellular carcinoma (HCC) remain a major
hurdle in its management. Appropriate staging and treatment selection may alleviate the …
hurdle in its management. Appropriate staging and treatment selection may alleviate the …
Liver Transplant in Patients with Hepatocarcinoma: Imaging Guidelines and Future Perspectives Using Artificial Intelligence
MD Pomohaci, MC Grasu, RL Dumitru, M Toma… - Diagnostics, 2023 - mdpi.com
Hepatocellular carcinoma is the most common primary malignant hepatic tumor and occurs
most often in the setting of chronic liver disease. Liver transplantation is a curative treatment …
most often in the setting of chronic liver disease. Liver transplantation is a curative treatment …
Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging
N Zhang, M Wu, Y Zhou, C Yu, D Shi, C Wang… - Frontiers in …, 2023 - frontiersin.org
Introduction The hepatobiliary-specific phase can help in early detection of changes in
lesion tissue density, internal structure, and microcirculatory perfusion at the microscopic …
lesion tissue density, internal structure, and microcirculatory perfusion at the microscopic …
Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
P Liu, W Li, G Qiu, J Chen, Y Liu, Z Wen… - Frontiers in …, 2023 - frontiersin.org
Objectives The present study aims at establishing a noninvasive and reliable model for the
preoperative prediction of glypican 3 (GPC3)-positive hepatocellular carcinoma (HCC) …
preoperative prediction of glypican 3 (GPC3)-positive hepatocellular carcinoma (HCC) …
[HTML][HTML] Prediction of glypican-3 expression in hepatocellular carcinoma using multisequence magnetic resonance imaging-based histology nomograms
SQ Li, CX Yang, CM Wu, JJ Cui… - Quantitative Imaging in …, 2024 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is often associated with the overexpression of
multiple proteins and genes. For instance, patients with HCC and a high expression of the …
multiple proteins and genes. For instance, patients with HCC and a high expression of the …
The expression of Ki-67 and Glypican -3 in hepatocellular carcinoma was evaluated by comparing DWI and 18F-FDG PET/CT
X Wang, L Li, L Wang, M Chen - Frontiers in Oncology, 2023 - frontiersin.org
Objective The value of DWI and 18F-FDG PET/CT in evaluating the expression of Ki-67 and
GPC-3 in HCC was compared. Materials and methods Ninety-four patients with primary …
GPC-3 in HCC was compared. Materials and methods Ninety-four patients with primary …
[HTML][HTML] Development of a novel tumor microenvironment-related radiogenomics model for prognosis prediction in hepatocellular carcinoma
Y Wang, B Gao, C Xia, X Peng, H Liu… - Quantitative Imaging in …, 2023 - ncbi.nlm.nih.gov
Background The tumour microenvironment (TME) has occupied a potent position in the
tumorigenesis and tumor progression of hepatocellular carcinoma (HCC). Radiogenomics is …
tumorigenesis and tumor progression of hepatocellular carcinoma (HCC). Radiogenomics is …
[HTML][HTML] Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score
V Brancato, M Cerrone, N Garbino… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Radiomics is a promising tool that may increase the value of magnetic
resonance imaging (MRI) for different tasks related to the management of patients with …
resonance imaging (MRI) for different tasks related to the management of patients with …
[HTML][HTML] 生物标志物在肝细胞癌诊断与治疗中的研究进展
徐飞麒， 张哲， 胡昂， 黄东胜 - 世界华人消化杂志, 2023 - wjgnet.com
肝细胞癌(hepatocellular carcinoma, HCC) 是最常见的原发性肝恶性肿瘤,
但因其早期诊断的困难, 复发率较高等特点, 患者预后仍较差. 因此寻求有效的早期诊断以及治疗 …
但因其早期诊断的困难, 复发率较高等特点, 患者预后仍较差. 因此寻求有效的早期诊断以及治疗 …
Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics …
Y Liu, Z Liu, X Li, W Zhou, L Lin, X Chen - Acta Radiologica, 2024 - journals.sagepub.com
Background Transcatheter arterial chemoembolization (TACE) is a mainstay treatment for
intermediate and advanced hepatocellular carcinoma (HCC), with the potential to enhance …
intermediate and advanced hepatocellular carcinoma (HCC), with the potential to enhance …